News
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.
Most people with MS who are treated with formulations of botulinum toxin to manage spasticity report being satisfied, a study ...
Multiomics study identifies 18 potential MS targets, opening paths to drug discovery and repurposing
Multiple sclerosis (MS) is an immune-mediated inflammatory disease characterized by demyelination and degeneration in the ...
Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.
3d
AZoLifeSciences on MSNEvidence for Neural Stem Cell-Based Therapies in Multiple SclerosisResearch indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results